Cutting edge: IL-2 immune complexes as a therapy for persistent virus infection

Journal of Immunology

Volumn 182, Issue 8, 2009, Pages 4512-4515

  Molloy, Michael J ^a   Zhang, Weijun ^a   Usherwood, Edward J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; GRANZYME B; INTERLEUKIN 2; INTERLEUKIN 2 ANTIBODY; MONOCLONAL ANTIBODY; PERFORIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CYTOTOXICITY; DRUG EFFICACY; HERPES VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSURVEILLANCE; INFECTION CONTROL; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; UPREGULATION; VIRUS LOAD; ANIMAL; C57BL MOUSE; IMMUNOLOGY; MOUSE; VIRUS INFECTION;

ANIMALS; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; VIRUS DISEASES;

EID: 65249095718     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804175     Document Type: Article

References (22)

1. Rickinson, A. B., and D. J. Moss. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15: 405-431. (Pubitemid 27169287)
2. Grogg, K. L., R. F. Miller, and A. Dogan. 2007. HIV infection and lymphoma. J. Clin. Pathol. 60: 1365-1372.
3. El-Far, M., R. Halwani, E. Said, L. Trautmann, M. Doroudchi, L. Janbazian, S. Fonseca, J. van Grevenynghe, B. Yassine-Diab, R. P. Sekaly, and E. K. Haddad. 2008. T-cell exhaustion in HIV infection. Curr. HIV/AIDS Rep. 5: 13-19.
4. + T-cell response. Nat. Rev. Immunol. 4: 595-602.
5. + T cells. J. Exp. Med. 184: 863-871.
6. + T cells but confers minimal survival advantage on CD4-deficient mice. Proc. Natl. Acad. Sci. USA 97: 2725-2730.
7. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434: 88-93.
8. Sarawar, S. R., B. J. Lee, S. K. Reiter, and S. P. Schoenberger. 2001. Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus. Proc. Natl. Acad. Sci. USA 98: 6325-6329.
9. + T cell responses. J. Immunol. 181: 7445-7448.
10. + memory T cells. Nature 441: 890-893.
11. + T cell responses in acute and chronic viral infections. Eur. J. Immunol. 37: 1502-1512.
12. Boyman, O., M. Kovar, M. P. Rubinstein, C. D. Surh, and J. Sprent. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927.
13. Blattman, J. N., J. M. Grayson, E. J. Wherry, S. M. Kaech, K. A. Smith, and R. Ahmed. 2003. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9: 540-547.
14. + T cell dysfunction and increase in murine gammaherpesvirus latent viral burden in the absence of 4-1BB ligand. J. Immunol. 178: 5227-5236.
15. Sunil-Chandra, N. P., S. Efstathiou, J. Arno, and A. A. Nash. 1992. Virological and pathological features of mice infected with murine γ-herpesvirus 68. J. Gen. Virol. 73: 2347-2356.
16. + T cell numbers are maintained during γ-herpesvirus reactivation in CD4-deficient mice. Proc. Natl. Acad. Sci. USA 95: 15565-15570.
17. + T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159: 105-117.
18. Virgin, H. W. 2005. Immune regulation of viral infection and vice versa. Immunol. Res. 32: 293-315. (Pubitemid 41158274)
19. + T cells expanded by post-exposure vaccination of γ-herpesvirus-infected CD4-deficient mice. J. Immunol. 168: 3477-3483.
20. Schwartzentruber, D. J. 2001. Guidelines for the safe administration of high-dose interleukin-2. J. Immunother. 24: 287-293.
21. + T cells to regulatory T cells. J. Immunol. 180: 5118-5129.
22. Kamimura, D., Y. Sawa, M. Sato, E. Agung, T. Hirano, and M. Murakami. 2006. IL-2 in vivo activities and antitumor efficacy enhanced by an anti-IL-2 mAb. J. Immunol. 177: 306-314. (Pubitemid 43939142)